Structured Summary
Abstract
An INK4 cyclin-dependent kinase inhibitor containing five ANKYRIN REPEATS. Aberrant expression of this protein has been associated with TESTICULAR CANCER.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
6 entry terms
- CDKN2D Protein
- Cyclin-Dependent Kinase Inhibitor 2D
- INK4D Protein
- p19INK4D Protein
- Cyclin Dependent Kinase Inhibitor 2D
- Cyclin Dependent Kinase Inhibitor p19
MeSH Record
Aspects Covered
30 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analysis, antagonists & inhibitors, biosynthesis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, deficiency, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
2006(1995)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Cyclin-Dependent Kinase Inhibitor p19. Medical Subject Headings (MeSH). 2026. Unique ID D050764. http://id.nlm.nih.gov/mesh/2026/D050764
- Cyclin-Dependent Kinase Inhibitor p19. In: Wikidata. https://www.wikidata.org/wiki/Q21105502